Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility
An Interventional Study Evaluating Telomere and Biological Aging Hallmarks Profiling to Guide an Integrative Traditional Chinese and Conventional Medicine Approach in Women With Post-Treatment Unexplained Infertility
BEYOND GENOMiX SA, AG, Ltd
15 participants
Jan 1, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to determine whether telomere profiling and other biological aging hallmarks can help identify underlying mechanisms of persistent infertility in women with post-treatment unexplained infertility. The study also evaluates whether a personalized integrative treatment guided by these biomarkers can improve reproductive outcomes. The study includes women aged 25 to 42 years who continue to experience infertility despite appropriate management of identifiable reproductive conditions and repeated attempts with assisted reproductive technologies (ART), such as intrauterine insemination (IUI) or in vitro fertilization (IVF). The main questions this study aims to answer are: * Can telomere and biological aging hallmarks profiling identify a biological aging phenotype associated with infertility? * Can an integrative treatment guided by these profiles improve clinical pregnancy outcomes? Participants will: * Undergo a baseline reproductive evaluation and blood-based assessment of telomeres and aging hallmarks. * Receive an integrative approach combining Traditional Chinese Medicine (TCM), targeted nutritional support, and standard fertility care. * Proceed with natural conception attempts or standard assisted reproductive technologies following the preconception phase. * Participants will be followed to assess pregnancy outcomes and changes in biological aging hallmarks.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants undergo baseline molecular profiling of biological aging biomarkers derived from the hallmarks of aging framework, with a primary focus on telomere-related parameters measured in peripheral blood leukocytes. Telomere analysis includes assessment of mean telomere length, the percentage of critically short ("super-short") telomeres, and telomere-length distribution profiles. Together, these biomarkers provide a measure of biological age and define molecular signatures of cellular aging relevant to ovarian and reproductive tissue function, including processes associated with telomere attrition, cellular senescence, and downstream aging hallmarks. Molecular parameters are assessed at baseline and, where applicable, longitudinally according to the study protocol for stratification and monitoring purposes.
Participants receive a personalized integrative intervention consisting of botanical formulations derived from Traditional Chinese Medicine (TCM) and targeted nutraceutical supplementation during a preconception period of 4 to 12 weeks. The intervention is administered alongside standard fertility care and is informed by biological aging-related molecular signatures. The integrative support is intended to address biological processes associated with aging hallmarks, including telomere-related cellular integrity, mitochondrial function, cellular senescence-associated pathways, oxidative balance, and tissue homeostasis.
Following completion of the preconception phase and confirmation of stabilization of biological aging-related molecular profiles associated with the hallmarks of aging, participants proceed to conception attempts either through natural cycles or through assisted reproductive technologies, including intrauterine insemination (IUI) or in vitro fertilization (IVF), according to clinical indication. Assisted reproductive procedures are conducted in accordance with standard clinical practice and local guidelines. The choice of conception method is determined by routine clinical criteria and participant preference. No experimental modifications to standard ART protocols are introduced as part of this intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07404969